{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:55:14Z","timestamp":1781913314438,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"DOI":"10.7759\/cureus.111172","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:41:42Z","timestamp":1781912502000},"source":"Crossref","is-referenced-by-count":0,"title":["Rethinking Serotonin in Depression: Toward a Modern Clinical Framework"],"prefix":"10.7759","author":[{"given":"Alexander","family":"Sheppert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01661-0","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence","volume":"28","author":"Moncrieff J","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023, 28:3243-56. 10.1038\/s41380-022-01661-0","journal-title":"Mol Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.07.031","article-title":"Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: a systematic review and meta-analyses of 23 studies","volume":"240","author":"Pech J","year":"2018","unstructured":"Pech J, Forman J, Kessing LV, Knorr U. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: a systematic review and meta-analyses of 23 studies. J Affect Disord. 2018, 240:6-16. 10.1016\/j.jad.2018.07.031","journal-title":"J Affect Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb01282.x","article-title":"Serotonin toxicity: a practical approach to diagnosis and treatment","volume":"187","author":"Isbister GK","year":"2007","unstructured":"Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust. 2007, 187:361-5. 10.5694\/j.1326-5377.2007.tb01282.x","journal-title":"Med J Aust"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani A","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018, 391:1357-66. 10.1016\/S0140-6736(17)32802-7","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier JC","year":"2010","unstructured":"Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010, 303:47-53. 10.1001\/jama.2009.1943","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003012.pub2","article-title":"Active placebos versus antidepressants for depression","volume":"2004","author":"Moncrieff J","year":"2004","unstructured":"Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database Syst Rev. 2004, 2004:CD003012. 10.1002\/14651858.CD003012.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner EH","year":"2008","unstructured":"Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008, 358:252-60. 10.1056\/NEJMsa065779","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch I","year":"2008","unstructured":"Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008, 5:e45. 10.1371\/journal.pmed.0050045","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare A","year":"2015","unstructured":"Cleare A, Pariante CM, Young AH, et al.. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015, 29:459-525. 10.1177\/0269881115581093","journal-title":"J Psychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer CJ","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017, 4:409-18. 10.1016\/S2215-0366(17)30015-9","journal-title":"Lancet Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman RS","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016, 22:238-49. 10.1038\/nm.4050","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.05.008","article-title":"Brain-derived neurotrophic factor signaling in depression and antidepressant action","volume":"90","author":"Castr\u00e9n E","year":"2021","unstructured":"Castr\u00e9n E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiatry. 2021, 90:128-36. 10.1016\/j.biopsych.2021.05.008","journal-title":"Biol Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v03n0105","article-title":"SSRI antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson JM","year":"2001","unstructured":"Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry. 2001, 3:22-7. 10.4088\/pcc.v03n0105","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref14","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction","volume":"62 Suppl 3","author":"Montejo AL","year":"2001","unstructured":"Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001, 62 Suppl 3:10-21.","journal-title":"J Clin Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.10.011","article-title":"Weight gain and associated factors in patients using newer antidepressant drugs","volume":"37","author":"Uguz F","year":"2015","unstructured":"Uguz F, Sahingoz M, Gungor B, Aksoy F, Askin R. Weight gain and associated factors in patients using newer antidepressant drugs. Gen Hosp Psychiatry. 2015, 37:46-8. 10.1016\/j.genhosppsych.2014.10.011","journal-title":"Gen Hosp Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565070-00003","article-title":"Antidepressants and sleep: a qualitative review of the literature","volume":"65","author":"Wilson S","year":"2005","unstructured":"Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs. 2005, 65:927-47. 10.2165\/00003495-200565070-00003","journal-title":"Drugs"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256181","article-title":"Hyponatraemia associated with psychotropic medications. A review of the literature and spontaneous reports","volume":"21","author":"Madhusoodanan S","year":"2002","unstructured":"Madhusoodanan S, Bogunovic OJ, Moise D, Brenner R, Markowitz S, Sotelo J. Hyponatraemia associated with psychotropic medications. A review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev. 2002, 21:17-29. 10.1007\/BF03256181","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","article-title":"Influence of antidepressants on hemostasis","volume":"9","author":"Halperin D","year":"2007","unstructured":"Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007, 9:47-59. 10.31887\/DCNS.2007.9.1\/dhalperin","journal-title":"Dialogues Clin Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075847","article-title":"Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials","volume":"384","author":"Noetel M","year":"2024","unstructured":"Noetel M, Sanders T, Gallardo-G\u00f3mez D, et al.. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2024, 384:e075847. 10.1136\/bmj-2023-075847","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102780","article-title":"A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depression","volume":"75","author":"Mavranezouli I","year":"2024","unstructured":"Mavranezouli I, Megnin-Viggars O, Pedder H, et al.. A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depression. EClinicalMedicine. 2024, 75:102780. 10.1016\/j.eclinm.2024.102780","journal-title":"EClinicalMedicine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2022-105964","article-title":"Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: a systematic review and network meta-analysis of randomised controlled trials","volume":"56","author":"Recchia F","year":"2022","unstructured":"Recchia F, Leung CK, Chin EC, et al.. Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med. 2022, 56:1375-80. 10.1136\/bjsports-2022-105964","journal-title":"Br J Sports Med"},{"key":"ref22","article-title":"Food, mood, and brain health: implications for the modern clinician","volume":"112","author":"Lachance L","year":"2015","unstructured":"Lachance L, Ramsey D. Food, mood, and brain health: implications for the modern clinician. Mo Med. 2015, 112:111-5.","journal-title":"Mo Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101556","article-title":"Improving sleep quality leads to better mental health: a meta-analysis of randomised controlled trials","volume":"60","author":"Scott AJ","year":"2021","unstructured":"Scott AJ, Webb TL, Martyn-St James M, Rowse G, Weich S. Improving sleep quality leads to better mental health: a meta-analysis of randomised controlled trials. Sleep Med Rev. 2021, 60:101556. 10.1016\/j.smrv.2021.101556","journal-title":"Sleep Med Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2024.104149","article-title":"The effect of bright light therapy on major depressive disorder: a systematic review and meta-analysis of randomised controlled trials","volume":"99","author":"Tong H","year":"2024","unstructured":"Tong H, Dong N, Lam CL, Lee TM. The effect of bright light therapy on major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. Asian J Psychiatr. 2024, 99:104149. 10.1016\/j.ajp.2024.104149","journal-title":"Asian J Psychiatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jclp.20659","article-title":"Perceived barriers to psychological treatments and their relationship to depression","volume":"66","author":"Mohr DC","year":"2010","unstructured":"Mohr DC, Ho J, Duffecy J, Baron KG, Lehman KA, Jin L, Reifler D. Perceived barriers to psychological treatments and their relationship to depression. J Clin Psychol. 2010, 66:394-409. 10.1002\/jclp.20659","journal-title":"J Clin Psychol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review","volume":"74","author":"McHugh RK","year":"2013","unstructured":"McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry. 2013, 74:595-602. 10.4088\/JCP.12r07757","journal-title":"J Clin Psychiatry"},{"key":"ref27","article-title":"Mental Health Gap Action Programme (mhGAP) Guideline for Mental, Neurological and Substance Use Disorders","author":"WHO","year":"2023","unstructured":"WHO. Mental Health Gap Action Programme (mhGAP) Guideline for Mental, Neurological and Substance Use Disorders. World Health Organization, Geneva; 2023."},{"key":"ref28","unstructured":"National Institute for Health and Care Excellence. Depression in adults. treatment and management. (2022). https:\/\/www.nice.org.uk\/guidance\/ng222."},{"key":"ref29","article-title":"","author":"American Psychiatric Association","year":"2010","unstructured":"American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. APA, Arlington, VA; 2010. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/503301-rethinking-serotonin-in-depression-toward-a-modern-clinical-framework","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:41:43Z","timestamp":1781912503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/503301-rethinking-serotonin-in-depression-toward-a-modern-clinical-framework"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.111172","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}